Invivo Therapeutics (NVIV) Reports Top-Line Results from Contemporary Thoracic SCI Registry Study
Tweet Send to a Friend
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) today announced top-line findings from its CONTEMPO Registry Study, designed to provide comprehensive natural ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
